Published in
Taylor and Francis Group, Leukemia & Lymphoma, 10(60), p. 2588-2590, 2019
DOI: 10.1080/10428194.2019.1585838
Links
Tools
Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML
Journal article published in 2019 by
Evgenii Shumilov,
Johanna Flach,
Raphael Joncourt,
Naomi Porret,
Gertrud Wiedemann 
,
Urban Novak,
Eva Gfeller,
Barbara Jeker,
Ursula Amstutz,
Thomas Pabst,
Ulrike Bacher
,
Urban Novak,
Eva Gfeller,
Barbara Jeker,
Ursula Amstutz,
Thomas Pabst,
Ulrike Bacher
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 